Immunotherapy drug capable of eliminating tumors in some early-stage cancers: Study
(NEW YORK) -- A new study in the New England Journal of Medicine suggests that some people with early-stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab.In the study, 82 out of 103 participants responded so well to the drug that they no longer needed an operation.While the results are promising, the study was conducted at a single hospital — Memorial Sloan Kettering […]